fda regulations on semaglutide approves Ozempic® (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease Hims Inc. - Novo Nordisk's

Ozempic injection is approved to: help manage type 2 diabetes in adults lower the risk of serious heart problems in adults who have type 2 diabetes and heart disease lower the risk of worsening kidney disease and death from cardiovascular (heart or blood vessel) disease in adults who have type 2 diabetes and chronic (long-term) kidney disease However, doctors may also prescribe Ozempic off-label for weight loss in: adults and children ages 12 years and older with obesity adults with overweight and at least one weight-related condition, such as high blood pressure or high cholesterol To find out whether Ozempic may be right for you, talk with your doctor

Perhaps, I thought, there were nuances that Id missed

doi: 10.1038/s41586-024-07185-7 157 HarringtonJ

G.ZanchiM

Additionally, adhering to recommendations for healthy eating and physical activity can help maintain weight loss even after stopping the medication and promote overall good health

Your bones are the frame, your muscles are the beams and supports, and your nutrition is the foundation